Dihydroorotate dehydrogenase is a target for the biological effects of leflunomide

被引：0
|
作者：
Williamson, RA
Yea, CM
Robson, PA
Curnock, AP
Gadher, S
Hambleton, AB
Woodward, K
Bruneau, JM
Hambleton, P
SpinellaJaegle, S
Morand, P
Courtin, O
Sautes, C
Westwood, R
Hercend, T
Kuo, EA
Ruuth, E
机构：
[1] ROUSSEL UCLAF,DEPT TOXICOL,F-93235 ROMAINVILLE,FRANCE
[2] HOECHST MARION ROUSSEL,IMMUNOL DOMAIN,SWINDON,WILTS,ENGLAND
[3] INST CURIE,INSERM U255,PARIS,FRANCE
来源：
TRANSPLANTATION PROCEEDINGS | 1996年 / 28卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：3088 / 3091
页数：4
相关论文
共 50 条
  • [1] INHIBITION OF DIHYDROOROTATE DEHYDROGENASE BY THE IMMUNOSUPPRESSIVE AGENT LEFLUNOMIDE
    GREENE, S
    WATANABE, K
    BRAATZTRULSON, J
    LOU, L
    BIOCHEMICAL PHARMACOLOGY, 1995, 50 (06) : 861 - 867
  • [2] Dihydroorotate dehydrogenase as a herbicide target
    Duke, Stephen O.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (51)
  • [3] The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase
    Davis, JP
    Cain, GA
    Pitts, WJ
    Magolda, RL
    Copeland, RA
    BIOCHEMISTRY, 1996, 35 (04) : 1270 - 1273
  • [4] The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase
    Davis, IP
    Cain, GA
    Pitts, WI
    Magolda, RL
    Copeland, RA
    FASEB JOURNAL, 1996, 10 (06): : C23 - C23
  • [5] Dihydroorotate dehydrogenase: A drug target for the development of antimalarials
    Singh, Anju
    Maqbool, Mudasir
    Mobashir, Mohammad
    Hoda, Nasimul
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 125 : 640 - 651
  • [6] Dihydroorotate dehydrogenase: A potential target against schistosomiasis
    Nonato, Maria Cristina
    BIOPHYSICAL REVIEWS, 2021, 13 (06) : 1341 - 1341
  • [7] Molecular mechanism of the immunosuppressive effect of leflunomide in vivo: Inhibition of dihydroorotate dehydrogenase (DHODH)
    Slauson, S
    Silva, H
    Shorthouse, R
    Cao, W
    Morris, RE
    FASEB JOURNAL, 1998, 12 (04): : A621 - A621
  • [8] Multiple inhibitor analysis of the brequinar and leflunomide binding sites on human dihydroorotate dehydrogenase
    McLean, JE
    Neidhardt, EA
    Grossman, TH
    Hedstrom, L
    BIOCHEMISTRY, 2001, 40 (07) : 2194 - 2200
  • [9] Dihydroorotate dehydrogenase polymorphism influences the toxicity of leflunomide treatment in patients with rheumatoid arthritis
    Grabar, P. Bohanec
    Rozman, B.
    Logar, D.
    Praprotnik, S.
    Dolzan, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (08) : 1367 - 1368
  • [10] Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancer
    Madak, Joseph T.
    Bankhead, Armand, III
    Cuthbertson, Christine R.
    Showalter, Hollis D.
    Neamati, Nouri
    PHARMACOLOGY & THERAPEUTICS, 2019, 195 : 111 - 131
12345